
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression
Yanwei Luo, Yunfeng Fu, Rong Huang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Yanwei Luo, Yunfeng Fu, Rong Huang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Showing 26-50 of 71 citing articles:
Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis
Weitong Zhang, Zhenfen Wang, Guohao Cai, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 2717-2731
Open Access | Times Cited: 28
Weitong Zhang, Zhenfen Wang, Guohao Cai, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 2717-2731
Open Access | Times Cited: 28
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Yi Li, Anqi Wu, Lin Chen, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Yi Li, Anqi Wu, Lin Chen, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma
Jin Yan, Lisen Li, Tongtong Zhu, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 12, pp. 152688-152688
Closed Access | Times Cited: 33
Jin Yan, Lisen Li, Tongtong Zhu, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 12, pp. 152688-152688
Closed Access | Times Cited: 33
Emerging roles of circular RNAs in liver cancer
Corentin Louis, Delphine Leclerc, Cédric Coulouarn
JHEP Reports (2021) Vol. 4, Iss. 2, pp. 100413-100413
Open Access | Times Cited: 26
Corentin Louis, Delphine Leclerc, Cédric Coulouarn
JHEP Reports (2021) Vol. 4, Iss. 2, pp. 100413-100413
Open Access | Times Cited: 26
Circular RNAs: new biomarkers of chemoresistance in cancer
Jiaqi Wang, Yi Zhang, Lianyu Liu, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 421-436
Open Access | Times Cited: 25
Jiaqi Wang, Yi Zhang, Lianyu Liu, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 421-436
Open Access | Times Cited: 25
Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies
Xueping Tao, Yongfu Shao, Jianing Yan, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 437-457
Open Access | Times Cited: 24
Xueping Tao, Yongfu Shao, Jianing Yan, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 437-457
Open Access | Times Cited: 24
Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis
Yong Wang, Rongfen Gao, Jinpeng Li, et al.
Aging (2020) Vol. 12, Iss. 10, pp. 9793-9806
Open Access | Times Cited: 27
Yong Wang, Rongfen Gao, Jinpeng Li, et al.
Aging (2020) Vol. 12, Iss. 10, pp. 9793-9806
Open Access | Times Cited: 27
Circular RNAs and cancer: Opportunities and challenges
Carla Solé, Charles H. Lawrie
Advances in clinical chemistry (2020), pp. 87-146
Closed Access | Times Cited: 24
Carla Solé, Charles H. Lawrie
Advances in clinical chemistry (2020), pp. 87-146
Closed Access | Times Cited: 24
The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
Song Zhang, Ying Zhou, Yanan Wang, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1860-1883
Closed Access | Times Cited: 24
Song Zhang, Ying Zhou, Yanan Wang, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1860-1883
Closed Access | Times Cited: 24
Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis
Hui Sheng, Xueling Wang
Anti-Cancer Drugs (2022)
Closed Access | Times Cited: 14
Hui Sheng, Xueling Wang
Anti-Cancer Drugs (2022)
Closed Access | Times Cited: 14
Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
Guocheng Rao, Peng Xi, Yan Tian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Guocheng Rao, Peng Xi, Yan Tian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines
Chunjie Wen, Ge Xu, Shuai He, et al.
Journal of Cancer (2020) Vol. 11, Iss. 13, pp. 3816-3826
Open Access | Times Cited: 21
Chunjie Wen, Ge Xu, Shuai He, et al.
Journal of Cancer (2020) Vol. 11, Iss. 13, pp. 3816-3826
Open Access | Times Cited: 21
Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis
Wei Fan, Lei Chen, Xiaojuan Wu, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 743-755
Open Access | Times Cited: 20
Wei Fan, Lei Chen, Xiaojuan Wu, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 743-755
Open Access | Times Cited: 20
Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles
Kedeerya Aishanjiang, Xindong Wei, Yi Fu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Kedeerya Aishanjiang, Xindong Wei, Yi Fu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances
Yucheng Zhang, Yali Wang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Yucheng Zhang, Yali Wang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance
Fanhua Kang, Yuanliang Yan, Yuanhong Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Fanhua Kang, Yuanliang Yan, Yuanhong Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway
Zhigang Hu, Pengxin Zhao, Kaili Zhang, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 685, pp. 108353-108353
Closed Access | Times Cited: 20
Zhigang Hu, Pengxin Zhao, Kaili Zhang, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 685, pp. 108353-108353
Closed Access | Times Cited: 20
The Roles of circRNAs in Liver Cancer Immunity
Ying Tang, Mei Jiang, Haimei Jiang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 17
Ying Tang, Mei Jiang, Haimei Jiang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 17
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance
Yujun Zhou, Xingkang Mao, Rui Peng, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 14, pp. 2033-2043
Open Access | Times Cited: 12
Yujun Zhou, Xingkang Mao, Rui Peng, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 14, pp. 2033-2043
Open Access | Times Cited: 12
Circular RNA is a popular molecule in tumors of the digestive system (Review)
Hao‐Ying Wang, Yuping Wang, Xi Zeng, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 1, pp. 21-42
Open Access | Times Cited: 18
Hao‐Ying Wang, Yuping Wang, Xi Zeng, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 1, pp. 21-42
Open Access | Times Cited: 18
Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
Rui Liao, Lei Liu, Jian Zhou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Rui Liao, Lei Liu, Jian Zhou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Review of novel functions and implications of circular RNAs in hepatocellular carcinoma
Zheng Liu, Fangming Yang, Zhun Xiao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Zheng Liu, Fangming Yang, Zhun Xiao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6